DLL4 (Navicixizumab) Recombinant Monoclonal Antibody

• Gene Aliases:

  AOS6 antibody; Delta 4 antibody; delta 4 precursor antibody; Delta ligand 4 antibody; delta ligand 4 precursor antibody; Delta like 4 antibody; Delta like 4 homolog antibody; Delta like 4 protein antibody; Delta like canonical Notch ligand 4 antibody; Delta like protein 4 antibody; Delta-like 4 (Drosophila) antibody; Delta-like protein 4 antibody; Delta4 antibody; DLL 4 antibody; Dll4 antibody; DLL4_HUMAN antibody; Drosophila Delta homolog 4 antibody; hdelta2 antibody; Homeobox protein DLL-4 antibody; MGC126344 antibody; Notch ligand delta 2 antibody; Notch ligand DLL4 antibody; Notch ligand DLL4 precursor antibody; XDLL-4 antibody; Navicixizumab

• UniProt:

  Q9NR61

• Antigen Species:

  Human

• Reactivity:

  Human

• Target Antigen:

  Recombinant Human DLL4 protein

• Target:

  DLL4

• Clonality:

  Monoclonal

• Conjugation:

  Non-conjugated

• Field of Research:

  Epigenetics and Nuclear Signaling; Neuroscience; Cell biology

• Purification Method:

  Affinity-chromatography

• Form:

  Liquid

• Storage Conditions:

  Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

• Antibody Type:

  Recombinant Antibody

• Clone ID:

  14C2

• Tested Applications:

  ELISA; Recommended dilution: ELISA:1:5000-1:50000

• Isotype:

  IgG2